These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 23225390

  • 1. Impact of aging on the progression of neuropathy after liver transplantation in transthyretin Val30Met amyloidosis.
    Koike H, Hashimoto R, Tomita M, Kawagashira Y, Iijima M, Nakamura T, Watanabe H, Kamei H, Kiuchi T, Sobue G.
    Muscle Nerve; 2012 Dec; 46(6):964-70. PubMed ID: 23225390
    [Abstract] [Full Text] [Related]

  • 2. Outcome of liver transplantation for familial amyloidotic polyneuropathy.
    Sharma P, Perri RE, Sirven JE, Zeldenrust SR, Brandhagen DJ, Rosen CB, Douglas DD, Mulligan DC, Rakela J, Wiesner RH, Balan V.
    Liver Transpl; 2003 Dec; 9(12):1273-80. PubMed ID: 14625827
    [Abstract] [Full Text] [Related]

  • 3. Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met.
    Tsuchiya-Suzuki A, Yazaki M, Kametani F, Sekijima Y, Ikeda S.
    Hum Pathol; 2011 Feb; 42(2):236-43. PubMed ID: 21056899
    [Abstract] [Full Text] [Related]

  • 4. Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy.
    Koike H, Ando Y, Ueda M, Kawagashira Y, Iijima M, Fujitake J, Hayashi M, Yamamoto M, Mukai E, Nakamura T, Katsuno M, Hattori N, Sobue G.
    J Neurol Sci; 2009 Dec 15; 287(1-2):178-84. PubMed ID: 19709674
    [Abstract] [Full Text] [Related]

  • 5. Amyloid Polyneuropathy and Myocardial Amyloidosis 10 Years after Domino Liver Transplantation from a Patient with a Transthyretin Ser50Arg Mutation.
    Matsushima M, Yabe I, Tsuda M, Sakakibara M, Shimamura T, Sasaki H.
    Intern Med; 2017 Dec 01; 56(23):3231-3235. PubMed ID: 28943540
    [Abstract] [Full Text] [Related]

  • 6. Risk of transmission of systemic transthyretin amyloidosis after domino liver transplantation.
    Lladó L, Baliellas C, Casasnovas C, Ferrer I, Fabregat J, Ramos E, Castellote J, Torras J, Xiol X, Rafecas A.
    Liver Transpl; 2010 Dec 01; 16(12):1386-92. PubMed ID: 21117248
    [Abstract] [Full Text] [Related]

  • 7. Progression of cardiomyopathy and neuropathy after liver transplantation in a patient with familial amyloidotic polyneuropathy caused by tyrosine-77 transthyretin variant.
    García-Herola A, Prieto M, Pascual S, Berenguer M, López-Viedma B, Mir J, Vilchez JJ, Berenguer J.
    Liver Transpl Surg; 1999 May 01; 5(3):246-8. PubMed ID: 10226117
    [Abstract] [Full Text] [Related]

  • 8. Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis.
    Koike H, Hashimoto R, Tomita M, Kawagashira Y, Iijima M, Tanaka F, Sobue G.
    Amyloid; 2011 Jun 01; 18(2):53-62. PubMed ID: 21463231
    [Abstract] [Full Text] [Related]

  • 9. Value of renal biopsy in the prognosis of liver transplantation in familial amyloid polyneuropathy ATTR Val30Met patients.
    Oguchi K, Takei Y, Ikeda S.
    Amyloid; 2006 Jun 01; 13(2):99-107. PubMed ID: 16911964
    [Abstract] [Full Text] [Related]

  • 10. Poor outcome after liver transplantation for transthyretin amyloid neuropathy in a family with an Ala36Pro transthyretin mutation: case report.
    Muller KR, Padbury R, Jeffrey GP, Poplawski NK, Thompson P, Tonkin A, Harley HA.
    Liver Transpl; 2010 Apr 01; 16(4):470-3. PubMed ID: 20373457
    [Abstract] [Full Text] [Related]

  • 11. Severe congestive heart failure with cardiac liver cirrhosis 10 years after orthotopic liver transplantation for familial amyloidotic polyneuropathy.
    Sakashita N, Ando Y, Haraoka K, Terazaki H, Yamashita T, Nakamura M, Takeya M.
    Pathol Int; 2006 Jul 01; 56(7):408-12. PubMed ID: 16792551
    [Abstract] [Full Text] [Related]

  • 12. Cardiac and peripheral vasomotor autonomic functions in late-onset transthyretin Val30Met familial amyloid polyneuropathy.
    Koike H, Nakamura T, Hashizume A, Nishi R, Ikeda S, Kawagashira Y, Iijima M, Katsuno M, Sobue G.
    J Neurol; 2017 Nov 01; 264(11):2293-2302. PubMed ID: 28983659
    [Abstract] [Full Text] [Related]

  • 13. A homozygote case of familial amyloid polyneuropathy amyloidgenic transthyretin Val30Met in a non-endemic area.
    Kumabe Y, Miura A, Yamashita T, Oshima T, Misumi Y, Ueda M, Obayashi K, Horibata Y, Jono H, Ando Y, Uchino M.
    Amyloid; 2011 Jun 01; 18 Suppl 1():169-70. PubMed ID: 21838475
    [No Abstract] [Full Text] [Related]

  • 14. Upper limb neuropathy such as carpal tunnel syndrome as an initial manifestation of ATTR Val30Met familial amyloid polyneuropathy.
    Tojo K, Tsuchiya-Suzuki A, Sekijima Y, Morita H, Sumita N, Ikeda S.
    Amyloid; 2010 Mar 01; 17(1):32-5. PubMed ID: 20132088
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of diflunisal on autonomic dysfunction of late-onset familial amyloid polyneuropathy (TTR Val30Met) in a Japanese endemic area.
    Takahashi R, Ono K, Shibata S, Nakamura K, Komatsu J, Ikeda Y, Ikeda T, Samuraki M, Sakai K, Iwasa K, Kayano D, Yamada M.
    J Neurol Sci; 2014 Oct 15; 345(1-2):231-5. PubMed ID: 25060417
    [Abstract] [Full Text] [Related]

  • 16. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
    Ando Y, Terazaki H, Nakamura M, Ando E, Haraoka K, Yamashita T, Ueda M, Okabe H, Sasaki Y, Tanihara H, Uchino M, Inomata Y.
    Transplantation; 2004 Feb 15; 77(3):345-9. PubMed ID: 14966406
    [Abstract] [Full Text] [Related]

  • 17. Epidemiology of familial amyloid polyneuropathy in Japan: Identification of a novel endemic focus.
    Kato-Motozaki Y, Ono K, Shima K, Morinaga A, Machiya T, Nozaki I, Shibata-Hamaguchi A, Furukawa Y, Yanase D, Ishida C, Sakajiri K, Yamada M.
    J Neurol Sci; 2008 Jul 15; 270(1-2):133-40. PubMed ID: 18410945
    [Abstract] [Full Text] [Related]

  • 18. [A sporadic case of late-onset familial amyloid polyneuropathy type I (transthyretin Met 30-associated familial amyloid polyneuropathy) inborn habitant of Ehime prefecture].
    Harada T, Ishizaki F, Togo M, Yamashita H, Nitta K, Date Y, Nakazato M, Yamamura Y, Nakamura S.
    No To Shinkei; 2002 Jul 15; 54(7):615-9. PubMed ID: 12187722
    [Abstract] [Full Text] [Related]

  • 19. Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative?
    Ericzon BG, Wilczek HE, Larsson M, Wijayatunga P, Stangou A, Pena JR, Furtado E, Barroso E, Daniel J, Samuel D, Adam R, Karam V, Poterucha J, Lewis D, Ferraz-Neto BH, Cruz MW, Munar-Ques M, Fabregat J, Ikeda S, Ando Y, Heaton N, Otto G, Suhr O.
    Transplantation; 2015 Sep 15; 99(9):1847-54. PubMed ID: 26308415
    [Abstract] [Full Text] [Related]

  • 20. Impact of liver transplantation on familial amyloidotic polyneuropathy (FAP) patients' symptoms and complications.
    Suhr OB.
    Amyloid; 2003 Aug 15; 10 Suppl 1():77-83. PubMed ID: 14640045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.